Alsabbagh MW, Eurich D, Lix LM, Wilson TW, Blackburn DF. Does the association between adherence to statin medications and mortality depend on measurement approach? A retrospective cohort study. BMC Medical Research Methodology 2017. [Accepted] DOI: 10.1186/s12874-017-0339-z
Kosar L, Alsabbagh MW, Lu X, Lix L, Shevchuk Y, Teare G, Champagne A, Blackburn DF. Self-monitoring Blood Glucose Test Strip Utilization in Saskatchewan. Can J Diabetes 2017. [Accepted]
Grindrod K, Alsabbagh MW. Managing medications during Ramadan fasting. CPJ 2017 [Accepted] DOI: 10.1177/1715163517700840
Barbara Farrell, Lisa Richardson, Lalitha Raman-Wilms, David de Launay, Mhd Wasem Alsabbagh, James Conklin. Self-efficacy for deprescribing: a survey for health care professionals using evidence-based deprescribing guidelines. Res Social Adm Pharm. 2017 Jan 28. pii: S1551-7411(17)30055-4. doi: 10.1016/j.sapharm.2017.01.003
Ziegler B, Alsabbagh MW, Houle S, Wenger L, Church D, Waite N. Protecting our patients by protecting ourselves: An analysis of the personal influenza immunization rate of Ontario community pharmacists. Can Pharm J. 2016 Jul;149(4):246-55. doi: 10.1177/1715163516651630.
Alsabbagh MW, Lix LM, Eurich D, Wilson TW, Blackburn DF. Multiple versus single-domain measurements of socio-economic status (SES) for predicting non-adherence to statin medications: an observational population-based cohort study. Med Care 2016 Feb;54(2):195-204.
Renoux C, Lix LM, Patenaude V, Bresee LC, Paterson JM, Lafrance JP, Tamim H, Mahmud SM, Alsabbagh MW, Hemmelgarn B, Dormuth CR, Ernst P; and the Canadian Network of Observational Drug Effect Studies (CNODES). Investigators. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis. Clin J Am Soc Nephrol. 2015 Oct 7;10(10):1716-22.
Alsabbagh MW, Mansell K, Lix LM, Teare G, Shevchuk Y, Lu X, Champagne A, Blackburn DF.Trends in prevalence, incidence and pharmacologic management of diabetes among seniors newly admitted to long-term care facilities in Saskatchewan between 2003 and 2011 CJD. 2015 Apr;39(2):138-45.
Alsabbagh MW, Lemstra M, Eurich D, Lix LM, Wilson TW, Watson E, Blackburn DF. Socioeconomic status and nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Value Health. 2014;17(2):288-296.
Lemstra M, Alsabbagh MW. Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis. Patient Prefer Adherence. 2014 Feb 13;8:211-8.
Alsabbagh MW, Dagenais J, Yan L, Lu X, Lix LM, Shevchuk Y, Teare GF, Blackburn DF. Use and misuse of ezetimibe: analysis of use and cost in Saskatchewan, a Canadian jurisdiction with broad access. Can J Cardiol. 2014 Feb;30(2):237-43.
Lemstra M, Alsabbagh MW, Rajakumar RJ, Rogers MR, Blackburn DF. Neighbourhood Income and Cardiac Rehabilitation Access as Determinants of Non-Attendance and Non-Completion. Can J Cardiol. 2013 Dec;29(12):1599-603.
Alsabbagh MW, Lemstra M, Eurich D, Wilson TW, Robertson P, Blackburn DF. Pharmacist intervention in cardiac rehabilitation: a randomized controlled trial. J Cardiopulm Rehabil Prev. 2012 Nov-Dec;32(6):394-9
For more on Dr. Alsabbagh's research, see his ResearchGate profile.
Dr. Alsabbagh’s research interests are in pharmacoepidemiology of chronic medications, in particular cardiovascular medications. His research includes employing administrative databases to examine the utilization and health-outcomes of chronic medications. Dr. Alsabbagh is also pursuing research investigating the comparative effectiveness and safety of chronic medications. The effect of health policy on appropriate use of chronic medications is also a major component of Dr. Alsabbagh’s research. Also, he evaluates the effects of pharmacists’ new services within expanding scope of practice on patients’ outcome and health system expenditures.